Lv42
650 积分 2024-05-05 加入
Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
6个月前
已完结
Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
8个月前
已完结
Icariside II Induces Apoptosis of Melanoma Cells Through the Downregulation of Survival Pathways
8个月前
已关闭
Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF‐1α/ATG5 axis
9个月前
已完结
[Consensus on pathological diagnosis of ductal carcinoma in situ of breast (2022 version)]
10个月前
已完结
The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast
10个月前
已完结
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial
10个月前
已完结
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline
10个月前
已完结
Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement
10个月前
已完结
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
10个月前
已完结
皖公网安备34019202002308
